Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen.
Purpose To characterize the molecular mechanism underpinning early-onset macular drusen (EOMD), a phenotypically severe subtype of age-related macular degeneration (AMD), in a subgroup of patients. Design Multicenter case series, in vitro experimentation, and retrospective analysis of previously re...
Những tác giả chính: | , , , , , , , , , , , , , |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Elsevier
2019
|
_version_ | 1826277664529317888 |
---|---|
author | Taylor, RL Poulter, JA Downes, SM McKibbin, M Khan, KN Inglehearn, CF Webster, AR Hardcastle, AJ Michaelides, M Bishop, PN Clark, SJ Black, GC United Kingdom Inherited Retinal Dystrophy Consortium Halford, S |
author_facet | Taylor, RL Poulter, JA Downes, SM McKibbin, M Khan, KN Inglehearn, CF Webster, AR Hardcastle, AJ Michaelides, M Bishop, PN Clark, SJ Black, GC United Kingdom Inherited Retinal Dystrophy Consortium Halford, S |
author_sort | Taylor, RL |
collection | OXFORD |
description | Purpose
To characterize the molecular mechanism underpinning early-onset macular drusen (EOMD), a phenotypically severe subtype of age-related macular degeneration (AMD), in a subgroup of patients.
Design
Multicenter case series, in vitro experimentation, and retrospective analysis of previously reported variants.
Participants
Seven families with apparently autosomal dominant EOMD.
Methods
Patients underwent a comprehensive ophthalmic assessment. Affected individuals from families A, B, and E underwent whole exome sequencing. The probands from families C, D, F, and G underwent Sanger sequencing analysis of the complement factor H (CFH) gene. Mutant recombinant factor H like-1 (FHL-1) proteins were expressed in HEK293 cells to assess the impact on FHL-1 expression and function. Previously reported EOMD-causing variants in CFH were reviewed.
Main Outcome Measures
Detailed clinical phenotypes, genomic findings, in vitro characterization of mutation effect on protein function, and postulation of the pathomechanism underpinning EOMD.
Results
All affected participants demonstrated bilateral drusen. The earliest reported age of onset was 16 years (median, 46 years). Ultra-rare (minor allele frequency [MAF], ≤0.0001) CFH variants were identified as the cause of disease in each family: CFH c.1243del, p.(Ala415ProfsTer39) het; c.350+1G→T het; c.619+1G→A het, c.380G→A, p.(Arg127His) het; c.694C→T p.(Arg232Ter) het (identified in 2 unrelated families in this cohort); and c.1291T→A, p.(Cys431Ser). All mutations affect complement control protein domains 2 through 7, and thus are predicted to impact both FHL-1, the predominant isoform in Bruch’s membrane (BrM) of the macula, and factor H (FH). In vitro analysis of recombinant proteins FHL-1R127H, FHL-1A415f/s, and FHL-1C431S demonstrated that they are not secreted, and thus are loss-of-function proteins. Review of 29 previously reported EOMD-causing mutations found that 75.8% (22/29) impact FHL-1 and FH. In total, 86.2% (25/29) of EOMD-associated variants cause haploinsufficiency of FH or FHL-1.
Conclusions
Early-onset macular drusen is an underrecognized, phenotypically severe subtype of AMD. We propose that haploinsufficiency of FHL-1, the main regulator of the complement pathway in BrM, where drusen develop, is an important mechanism underpinning the development of EOMD in a number of cases. Understanding the molecular basis of EOMD will shed light on AMD pathogenesis given their pathologic similarities.
|
first_indexed | 2024-03-06T23:32:19Z |
format | Journal article |
id | oxford-uuid:6c7b167b-17a4-4ac8-8efa-db8b7d0f340f |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T23:32:19Z |
publishDate | 2019 |
publisher | Elsevier |
record_format | dspace |
spelling | oxford-uuid:6c7b167b-17a4-4ac8-8efa-db8b7d0f340f2022-03-26T19:11:05ZLoss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6c7b167b-17a4-4ac8-8efa-db8b7d0f340fEnglishSymplectic ElementsElsevier2019Taylor, RLPoulter, JADownes, SMMcKibbin, MKhan, KNInglehearn, CFWebster, ARHardcastle, AJMichaelides, MBishop, PNClark, SJBlack, GCUnited Kingdom Inherited Retinal Dystrophy ConsortiumHalford, SPurpose To characterize the molecular mechanism underpinning early-onset macular drusen (EOMD), a phenotypically severe subtype of age-related macular degeneration (AMD), in a subgroup of patients. Design Multicenter case series, in vitro experimentation, and retrospective analysis of previously reported variants. Participants Seven families with apparently autosomal dominant EOMD. Methods Patients underwent a comprehensive ophthalmic assessment. Affected individuals from families A, B, and E underwent whole exome sequencing. The probands from families C, D, F, and G underwent Sanger sequencing analysis of the complement factor H (CFH) gene. Mutant recombinant factor H like-1 (FHL-1) proteins were expressed in HEK293 cells to assess the impact on FHL-1 expression and function. Previously reported EOMD-causing variants in CFH were reviewed. Main Outcome Measures Detailed clinical phenotypes, genomic findings, in vitro characterization of mutation effect on protein function, and postulation of the pathomechanism underpinning EOMD. Results All affected participants demonstrated bilateral drusen. The earliest reported age of onset was 16 years (median, 46 years). Ultra-rare (minor allele frequency [MAF], ≤0.0001) CFH variants were identified as the cause of disease in each family: CFH c.1243del, p.(Ala415ProfsTer39) het; c.350+1G→T het; c.619+1G→A het, c.380G→A, p.(Arg127His) het; c.694C→T p.(Arg232Ter) het (identified in 2 unrelated families in this cohort); and c.1291T→A, p.(Cys431Ser). All mutations affect complement control protein domains 2 through 7, and thus are predicted to impact both FHL-1, the predominant isoform in Bruch’s membrane (BrM) of the macula, and factor H (FH). In vitro analysis of recombinant proteins FHL-1R127H, FHL-1A415f/s, and FHL-1C431S demonstrated that they are not secreted, and thus are loss-of-function proteins. Review of 29 previously reported EOMD-causing mutations found that 75.8% (22/29) impact FHL-1 and FH. In total, 86.2% (25/29) of EOMD-associated variants cause haploinsufficiency of FH or FHL-1. Conclusions Early-onset macular drusen is an underrecognized, phenotypically severe subtype of AMD. We propose that haploinsufficiency of FHL-1, the main regulator of the complement pathway in BrM, where drusen develop, is an important mechanism underpinning the development of EOMD in a number of cases. Understanding the molecular basis of EOMD will shed light on AMD pathogenesis given their pathologic similarities. |
spellingShingle | Taylor, RL Poulter, JA Downes, SM McKibbin, M Khan, KN Inglehearn, CF Webster, AR Hardcastle, AJ Michaelides, M Bishop, PN Clark, SJ Black, GC United Kingdom Inherited Retinal Dystrophy Consortium Halford, S Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen. |
title | Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen. |
title_full | Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen. |
title_fullStr | Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen. |
title_full_unstemmed | Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen. |
title_short | Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen. |
title_sort | loss of function mutations in the cfh gene affecting alternatively encoded factor h like 1 protein cause dominant early onset macular drusen |
work_keys_str_mv | AT taylorrl lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT poulterja lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT downessm lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT mckibbinm lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT khankn lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT inglehearncf lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT websterar lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT hardcastleaj lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT michaelidesm lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT bishoppn lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT clarksj lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT blackgc lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT unitedkingdominheritedretinaldystrophyconsortium lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen AT halfords lossoffunctionmutationsinthecfhgeneaffectingalternativelyencodedfactorhlike1proteincausedominantearlyonsetmaculardrusen |